Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7554481rdf:typepubmed:Citationlld:pubmed
pubmed-article:7554481lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C0019764lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C0242656lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C1413221lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C1515021lld:lifeskim
pubmed-article:7554481lifeskim:mentionsumls-concept:C2348205lld:lifeskim
pubmed-article:7554481pubmed:issue1lld:pubmed
pubmed-article:7554481pubmed:dateCreated1995-10-25lld:pubmed
pubmed-article:7554481pubmed:abstractTextThree-color automated flow cytometry was carried out on peripheral blood CD4+ and CD8+ T-lymphocytes of 42 HIV-positive patients using tri-color anti-CD4 or anti-CD8, phycoerythrin-anti-CD38, and fluorescein-anti-HLA-DR, mAbs to elucidate further the T-cell activation hypothesis recently proposed to explain CD4+ T-cell abnormalities observed during HIV infection. CD4+ CD38+ T-cells constituted the major part of circulating CD4+ T-cells in HIV-infected patients and their HLA-DR molecule positivity increased as their disease progressed. The level of CD38 and HLA-DR expression on CD4+ T-cells was positively correlated to that of CD8+ T-cells and to the level of beta 2-microglobulin. Next, to determine whether CD38 expression was associated with a selective expansion or deletion of V beta gene-defined subsets, we compared the V beta gene frequencies between CD38+ and CD38- T-cells from HIV-infected CDC stage II patients using 13 mAbs specific to V beta families. While selective expansion of certain V beta families was observed in CD4+ and CD8+ T-cells the T-cell receptor V beta subset distribution was similar among CD38+ and CD38-, CD4+ and CD8+ T-cells, suggesting that CD38+ expression was either independent of an HIV-encoded antigen-driven process or rather indicative of T-cell immaturity. It is proposed that the phenotype of circulating CD4+ and CD8+ T-cells of HIV-infected patients is a feature of two different mechanisms: (i) an in vitro activation state responsible for increased DR expression and selective expansion of V beta gene-defined subsets, and (ii) T-cell immaturity due to an increased turnover of these cells and accounting for increased CD38 expression.lld:pubmed
pubmed-article:7554481pubmed:languageenglld:pubmed
pubmed-article:7554481pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:citationSubsetIMlld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7554481pubmed:statusMEDLINElld:pubmed
pubmed-article:7554481pubmed:monthOctlld:pubmed
pubmed-article:7554481pubmed:issn0090-1229lld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:GilbertDDlld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:TropDDlld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:HumbertGGlld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:MichelYYlld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:Borsa-LebasFFlld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:Jouen-BeadesF...lld:pubmed
pubmed-article:7554481pubmed:authorpubmed-author:RamzaouiSSlld:pubmed
pubmed-article:7554481pubmed:issnTypePrintlld:pubmed
pubmed-article:7554481pubmed:volume77lld:pubmed
pubmed-article:7554481pubmed:ownerNLMlld:pubmed
pubmed-article:7554481pubmed:authorsCompleteYlld:pubmed
pubmed-article:7554481pubmed:pagination33-41lld:pubmed
pubmed-article:7554481pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:meshHeadingpubmed-meshheading:7554481-...lld:pubmed
pubmed-article:7554481pubmed:year1995lld:pubmed
pubmed-article:7554481pubmed:articleTitleDuring HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.lld:pubmed
pubmed-article:7554481pubmed:affiliationGroupe de Recherche en Immunopathologie, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides, France.lld:pubmed
pubmed-article:7554481pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7554481pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7554481lld:pubmed